For patients on warfarin or immunosuppressants, which herbal supplements have the strongest clinical evidence of harm?
Executive summary
For patients on warfarin, the herbs with the clearest clinical signals for harm—either potentiating bleeding or reducing anticoagulant effect—include St. John’s wort (documented to lower anticoagulant activity), garlic/ginger/ginkgo and several others linked to increased bleeding or INR changes, and a cluster of herbs repeatedly reported in case series and systematic reviews such as cranberry, chamomile, green tea, red clover, ginseng and danshen [1] [2] [3] [4]. For immunosuppressants, St. John’s wort stands out with documented, clinically significant interactions (notably with cyclosporine) that reduce drug levels and clinical efficacy [5] [6].
1. The herbs with the strongest clinical signal of harm for warfarin patients
Systematic reviews and clinical-update papers converge on a relatively small list of botanicals most often implicated in clinically meaningful warfarin interactions: St. John’s wort (associated with loss of anticoagulant activity), garlic, ginger, ginkgo, green tea, chamomile, cranberry, red clover, cannabis and danshen have each been reported to potentiate bleeding or alter INR in clinical reports, case series or trials, and multiple reviews flag these repeatedly as having the most evidence of harm [1] [2] [3] [4] [7].
2. St. John’s wort and immunosuppressants — the clearest documented danger
Among immunosuppressants the clearest and best-documented herb–drug interaction is St. John’s wort reducing levels and clinical efficacy of drugs like cyclosporine; national research summaries and provider digests note clinically significant interactions between St. John’s wort and cyclosporine as established [5] [6], and separate reviews report St. John’s wort reducing warfarin activity in patients stabilized on therapy [8].
3. Which herbs most consistently increase bleeding risk and why the list is long
Multiple comprehensive reviews and observational studies report that the majority of cited herb–warfarin interactions increase warfarin effect and bleeding risk—one update counted dozens of herbs (45–84% of reported herbs in different reviews) that potentiate warfarin’s effect—examples named repeatedly include garlic, ginger, ginkgo, green tea, chamomile, cannabis, and danshen [2] [4] [9]. These herbs are implicated through diverse mechanisms: direct effects on platelet function or coagulation, interference with vitamin K pathways, or inhibition of warfarin-metabolizing enzymes [3] [4].
4. Which herbs have weaker or conflicting evidence despite public concern
For several commonly cited botanicals the clinical trial evidence is mixed or low-quality: cranberry has case reports but human trials generally failed to show a significant effect on warfarin metabolism or INR; ginseng trials show small or inconsistent effects; ginkgo’s bleeding risk is suggested by some databases but meta-analyses and trials are inconclusive—guidance from national centers notes conflicting evidence and recommends caution or monitoring rather than absolute prohibition [10] [6] [1].
5. Practical mechanisms and clinical implications clinicians should watch
The dominant mechanisms are pharmacokinetic—induction or inhibition of CYP enzymes that change warfarin or immunosuppressant levels—and pharmacodynamic effects on platelet aggregation or vitamin K pathways; reviews emphasize that herbs can both raise and lower anticoagulant effect, sometimes unpredictably, and that herb interactions are especially risky with drugs having narrow therapeutic indices such as warfarin and cyclosporine [4] [2] [5].
6. Evidence quality, hidden limits and recommended clinical posture
The literature is dominated by case reports, observational studies, small trials and in vitro work; systematic reviews caution that many interactions cannot be predicted with certainty because of poor standardization of herbal products and limited high-quality clinical trials, yet the cumulative clinical reports justify heightened surveillance—regular INR checks for warfarin patients who start or stop herbal products and avoidance or close monitoring when patients on cyclosporine or other immunosuppressants use St. John’s wort [11] [2] [6].
7. Bottom line for clinicians and policy-minded readers
Conservative clinical practice is warranted: treat St. John’s wort as a proven hazard for certain immunosuppressants and a possible disruptor of warfarin [5] [8], and regard garlic, ginger, ginkgo, green tea, chamomile, danshen, red clover, cannabis and similar agents as having the strongest clinical signals for increasing warfarin-related bleeding risk—monitoring or avoidance is the pragmatic approach given variable product quality and limited definitive trials [1] [4] [3].